The STEP 1 trial of semaglutide (the active ingredient in Ozempic and Wegovy) - published in The New England Journal of Medicine , 2021 - also reported secondary data showing modest lean mass reductions alongside the significant total weight loss the trial is known for
Evidence strength varies considerably by indication, and most body composition claims in healthy adults rest on mechanistic reasoning and practitioner-reported experience rather than robust controlled human trials
Muchos pacientes reportan que los efectos gastrointestinales son ms pronunciados durante los primeros das despus de cada inyeccin y especialmente tras cada aumento de dosis
Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
For some, this creates a cycle of reliance, anxiety, or shamefueling the very stigma these medications claim to solve
